Payer Almanac
About the data Sign in
Plan reportsServicesDrugsAppeals

Drugs that need prior authorization

Every Part D plan publishes a formulary, the list of drugs it covers, and marks the ones that need its approval first (prior authorization), that must follow a cheaper drug first (step therapy), or that it covers only up to a quantity. CMS collects every formulary each month. This is the drug side of prior authorization; the plans' reports and services cover medical care. October 2026, 2027 plans.
i
Where this comes from

CMS's monthly Part D formulary files: for each plan, its formulary, and for each drug on the formulary, whether it needs prior authorization, step therapy or a quantity limit. A drug here is one RxNorm drug concept (an ingredient, strength and form); shares are of the drugs on the plan's formulary.

From October each year the files describe the next year's plans, which go on sale then, so a month-to-month change is shown only between months of the same plan year. Members: each plan's enrollment that month, or the latest month we have; for next year's plans, today's enrollment of the same contract and plan number, so new plans count zero until they have members. Contract and parent figures are member-weighted across their plans.

The share of drugs needing approval says how much of the list carries a restriction, not how often members meet one: a plan can restrict many rarely used drugs, or a few common ones.

27.4%
of covered drugs need prior authorization
Medicare Advantage drug plans (MA-PD), member-weighted
26.9%
Stand-alone drug plans (PDP)
323 plans
41%
Quantity limits, MA-PD
step therapy 0.8%
3,468
Drugs on a typical MA-PD formulary
259 formularies across 4,711 plans

Share of covered drugs needing prior authorization, by month

Member-weighted across plans. Each line is one plan year; next year's plans appear from October.

By plan: H5774, October 2026

Plan Members Drugs on formulary Prior authorizationshare of drugs Change
i
Change

Change in the share of drugs needing prior authorization since the month before (Sep), in percentage points. Only months of the same plan year are compared: October 2026 is the first month of the 2027 plan year, so there's nothing to compare yet.

vs Sep
Step therapyQuantity limit Formulary
H5774-043 PLATINO PLUS (HMO D-SNP)Guidewell Mutual Holding Corporation 41,430 2,979 34.2% — 4.0% 34% 00027374
H5774-047 Ahorro Plus (HMO)Guidewell Mutual Holding Corporation 24,996 3,170 33.7% — 4.1% 33% 00027373
H5774-038 Enlace Plus (HMO)Guidewell Mutual Holding Corporation 6,103 3,170 33.7% — 4.1% 33% 00027373
H5774-022 Contigo Plus (HMO C-SNP)Guidewell Mutual Holding Corporation 2,931 3,170 33.7% — 4.1% 33% 00027373
H5774-031 Brillante (HMO-POS)Guidewell Mutual Holding Corporation 2,689 3,170 33.7% — 4.1% 33% 00027373
H5774-041 PLATINO ADVANCE (HMO D-SNP)Guidewell Mutual Holding Corporation 1,726 2,979 34.2% — 4.0% 34% 00027374
H5774-046 ContigoEnMente (HMO C-SNP)Guidewell Mutual Holding Corporation 1,160 3,170 33.7% — 4.1% 33% 00027373
H5774-035 Platino Enlace (HMO D-SNP)Guidewell Mutual Holding Corporation 930 2,979 34.2% — 4.0% 34% 00027374
H5774-049 Platino Uno (HMO D-SNP)Guidewell Mutual Holding Corporation 0 2,979 34.2% — 4.0% 34% 00027374
H5774-050 Platino Vita Plus (HMO D-SNP)Guidewell Mutual Holding Corporation 0 2,979 34.2% — 4.0% 34% 00027374

Members are projected from todays enrollment.